Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Doctor measuring patient's blood pressure | Image credit: Andrey Popov – stock.adobe.com

Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes

By Connor Iapoce

November 19th 2024

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.

Young man frustrated with finances | Image credit: master1305 – stock.adobe.com

Young Adults With Low Incomes Have Higher Diabetes Mortality Risk

By Hayden E. Klein

November 14th 2024

Diabetes | Image credit: Minerva Studio - stock.adobe.com.jpg

Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers

By Elzbieta Dziekonski, RN

November 13th 2024

AJMC Q&A with Dr Sanjula Jain | Background image credit: ipopba – stock.adobe.com

Rethinking Diabetes Care: Are New Therapies Adding Value or Cost?

By Hayden E. Klein

November 5th 2024

Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com

How Neighborhood Social Needs Drive Diabetes Care Disparities

By Hayden E. Klein

October 18th 2024

More News

September 12th 2017

Medtronic Announces Recall of Diabetes Infusion Sets

The problem caused an overdelivery of insulin in some cases. A design update in April 2017 corrected the problem but some patients still have lots of defective infusion sets.

September 12th 2017

Bringing Drugs to Market Costs Less Than Previously Thought, Study Finds

Christina Mattina

How much does it cost for a drug maker to develop a new drug? Prior estimates have put this figure as high as $2.7 billion, but a new study indicates that the median cost of development for 10 cancer drugs was actually $648 million-a substantial discrepancy.

September 12th 2017

CMS Must Add Virtual Providers, Revamp Payment for Diabetes Prevention Program

A group that represents both community-based and virtual providers finds many issues with CMS' proposal for Medicare's Diabetes Prevention Program.

September 11th 2017

Quest Moves to More Accurate, Nonfasting Cholesterol Test Method

As physicians treat patients with elevated low-density lipoprotein (LDL) cholesterol more aggressively with PCSK9 inhibitors and high-efficacy statins, a test that is more accurate at lower levels is essential.

September 11th 2017

Fitbit, Dexcom to Put CGM Data on Wrists of People With Diabetes

Dexcom's partnerships are giving people with diabetes technology that will be less invasive and use products that everyone else wears and uses: fitness trackers and smartphones.

September 8th 2017

5 Things Behind the Day of Action on Insulin Pricing

The "Day of Action" seeks to unite people with diabetes online and asks them to contact their representatives. Fixing the insulin pricing system in the United States will be difficult-even experts say it's very complex.

September 8th 2017

CDC: Progress in Reducing Stroke Deaths Has Stalled

Christina Mattina

The rate of stroke deaths, after declining for decades, is now on an alarming uptick, according to the CDC. In 3 out of 4 states, decreases in stroke deaths have slowed or reversed over time.

September 7th 2017

Phase 3 Results for Ertugliflozin Are Published, With FDA Action Pending

Three separate applications are pending involving the SGLT2 inhibitor.

September 6th 2017

Half of Americans Have Been Obese in Their Lifetime, Study Finds

The study uncovered differences by race and education level in lifetime obesity status.

September 5th 2017

Study Finds Genetic Links Between Diabetes, Heart Disease; Reveals Potential Drug Targets

Penn Medicine researchers led the analysis of genome sequence information that revealed 16 previously unreported areas connected to type 2 diabetes and 1 connected to coronary heart disease, with 8 variants tied to both conditions.

Podcast: This Week in Managed Care - Hurricane Relief Efforts, and Other Health News

September 3rd 2017

Podcast: This Week in Managed Care - Hurricane Relief Efforts, and Other Health News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

September 1st 2017

Sanofi Announces Tentative FDA Approval for Insulin Lispro

The rapid-acting insulin received tentative approval based on its similarity to Eli Lilly's Humalog.

September 1st 2017

White in September? If It's a Sock, It's About Peripheral Artery Disease

Desmond Bell, DPM, CWS, said the patients he's seeing in his wound clinic are getting younger, suggesting that the challenge of preventing complications from peripheral artery disease will increase.

This Week in Managed Care: September 1, 2017

September 1st 2017

This Week in Managed Care: September 1, 2017

This week, the top managed care stories included responses to the disaster in Houston after Hurricane Harvey; the approval of the first gene therapy in the United States; and a new cardiovascular indication for a popular drug to treat type 2 diabetes.

August 31st 2017

Liraglutide Improves Renal Outcomes in Type 2 Diabetes Patients With CV Risk

The study finds that the GLP-1 receptor agonist can slow progression of kidney disease, one of the most costly and debilitating complications of type 2 diabetes.

August 31st 2017

Report Finds Obesity Rates Leveling Off, but Still Far Too High

There are positive signs among the youngest children in states where adult obesity rates are highest, but the challenge is to continue that progress as these children get older.

August 29th 2017

A Study of Nearly 400 Children Asked How Many Followed Guidelines to Prevent Obesity. The Answer? Just One

According to the CDC, 8.9% of children aged 2 to 5 are obese and more than 20% of youth are obese by the time they are 12 to 19 years old.

August 29th 2017

Comorbidities in Patients With Heart Failure: Treating the Whole Patient

Laura Joszt, MA

Patients with heart failure tend to have other health issues, requiring cardiologists to understand how to care for heart failure while keeping in mind treatment for these other comorbidities, said panelists at the European Society of Cardiology Congress 2017, held August 26-30 in Barcelona, Spain.

August 28th 2017

Weight Gain in Early Pregnancy Has Greatest Effect on Childhood Obesity, Study Finds

The largest study of its type sought to pinpoint when the link between weight gain in pregnancy and childhood obesity occurs.

Podcast: This Week in Managed Care - When to Start Mammography, and Other Health News

August 26th 2017

Podcast: This Week in Managed Care - When to Start Mammography, and Other Health News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

August 26th 2017

Impact of Formulary Restrictions on Medication Use and Costs

Xian Shen, PhD Bruce C. Stuart, PhD Christopher A. Powers, PharmD Sarah E. Tom, PhD, MPH Laurence S. Magder, PhD Eleanor M. Perfetto, PhD, MS

Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.

August 26th 2017

"Diabetes Dilemma" Report Finds Room for Improvement in Medication Adherence

Christina Mattina

A new report from Express Scripts examines patterns of costs and utilization associated with adherence to diabetes medications among a commercially insured population.

August 25th 2017

Cost-Effectiveness Analysis of Vagal Nerve Blocking for Morbid Obesity

Jeffrey C. Yu, AB Bruce Wolfe, MD Robert I. Griffiths, ScD, MS Raul Rosenthal, MD Daniel Cohen, MA Iris Lin, PhD

This lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.

August 25th 2017

Liraglutide Gains New Indication for Reducing CV Event Risk

Christina Mattina

Novo Nordisk announced that its diabetes drug liraglutide (Victoza) has been approved by the FDA for a new indication: it can reduce the risk of major cardiovascular (CV) events in patients with type 2 diabetes (T2D) and existing CV disease.

This Week in Managed Care: August 25, 2017

August 25th 2017

This Week in Managed Care: August 25, 2017

This week, the top stories in managed care include a study on which mammogram recommendations to follow; findings that continuous glucose monitoring benefits patients with type 2 diabetes; and a new position statement on treating patients with diabetes and hypertension.

August 24th 2017

Predictive Tool Could Target Patients at Risk of Hypoglycemia-Related Utilization

Christina Mattina

Researchers have outlined a 6-item risk stratification tool that successfully predicted the likelihood that patients with diabetes will have a hypoglycemia-related emergency department visit or hospital admission.

August 23rd 2017

Dexcom Now Shipping CGM to Medicare Beneficiaries

A Dexcom spokeswoman said there are already 20,000 Medicare patients in the pipeline with almost no advertisement of the policy change.

August 22nd 2017

ADA Offers Position Statement on Diabetes and Hypertension

The American Diabetes Association (ADA) today offered a position statement on treating diabetes and hypertension for the first time since 2003.

August 22nd 2017

Does Childhood Obesity Start in the Brain?

Children who were obese or at risk of obesity had less activity in the brain's self-regulation centers.

August 21st 2017

Study: Dexcom CGM Benefits Type 2 Diabetes Patients Using Multiple Daily Insulin Injections

To avoid bias, the study did use aggressive titration protocols that might be found in a real-world setting. Still, patients using CGM saw greater reductions in A1C and more time in range.

...

32 33 34 35 36 37 38 39 40

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions